1h Free Analyst Time
The genomics market in the US is forecasted to grow by USD 9.24 billion during 2025-2030, accelerating at a CAGR of 12.9% during the forecast period. The report on the genomics market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in next generation sequencing and bioinformatics integration, increasing demand for creating and upgrading genome databases, integration of ai and ml in genomic data analysis.
The study identifies the acceleration of precision medicine and targeted oncology clinical integration as one of the prime reasons driving the genomics market in the US growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The genomics market in the US is segmented as below:
By Application
- Diagnostics
- Drug discovery
- Others
By End-User
- Hospitals and clinics
- Academics and research institutes
- Pharmaceuticals and biotechnology companies
- Others
By Solution
- Products
- Services
By Region
- North America
The report covers the following areas:
- Genomics market in the US sizing
- Genomics market in the US forecast
- Genomics market in the US industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Market Segmentation by Solution
11 Customer Landscape
12 Drivers, Challenges, and Opportunity
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global genomics market in us: Agilent Technologies Inc., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., LetsGetChecked, Myriad Genetics Inc., Natera Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., Personalis Inc., QIAGEN N.V., Revvity Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is acceleration of precision medicine and targeted oncology clinical integration."
According to the report, one of the major drivers for this market is the technological innovations in next generation sequencing and bioinformatics integration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Bio Rad Laboratories Inc.
- Caris Life Sciences
- CENTOGENE NV
- Danaher Corp.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Illumina Inc.
- LetsGetChecked
- Myriad Genetics Inc.
- Natera Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences Inc.
- Personalis Inc.
- QIAGEN N.V.
- Revvity Inc.
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corp.
